Kshamata M Shah1, B Ruth Clark2, Janet B McGill3, Catherine E Lang4, John Maynard5, Michael J Mueller6. 1. K.M. Shah, PT, PhD, Department of Physical Therapy, Arcadia University, Glenside, Pennsylvania. At the time of the study, Dr Shah was affiliated with the Program in Physical Therapy, Washington University School of Medicine, St Louis, Missouri. 2. B.R. Clark, PT, PhD, Program in Physical Therapy, Washington University School of Medicine. 3. J.B. McGill, MD, Division of Endocrinology, Metabolism and Lipid Research, Department of Medicine, Washington University School of Medicine. 4. C.E. Lang, PT, PhD, Program in Physical Therapy, Program in Occupational Therapy, Department of Neurology, Washington University School of Medicine. 5. J. Maynard, MS, MDDC, Albuquerque, New Mexico. 6. M.J. Mueller, PT, PhD, FAPTA, Program in Physical Therapy and Department of Radiology, Washington University School of Medicine, Campus Box 8502, 4444 Forest Park Ave, Ste 1101, St Louis, MO 63108-2212 (USA). muellerm@wustl.edu.
Abstract
BACKGROUND: Accumulation of advanced glycation end products (AGEs) is thought to contribute to limited joint mobility in people with diabetes mellitus (DM), but the relationships among AGEs, shoulder structural changes, movement, and disability are not understood. OBJECTIVE: The purpose of this study was to determine the differences and relationships among skin intrinsic fluorescence (SIF), a proxy measure of AGEs, biceps and supraspinatus tendon thickness, upper extremity movement, and disability in groups with and without DM. DESIGN: This was a cross-sectional, case-control study. METHODS: Fifty-two individuals participated: 26 with type 2 DM and 26 controls matched for sex, age, and body mass index. The main outcome measures were: SIF; biceps and supraspinatus tendon thickness; 3-dimensional peak shoulder motion; and Disability of the Arm, Shoulder and Hand (DASH) questionnaire scores. RESULTS: Mean SIF measurements were 19% higher in the DM group compared with the control group (P<.05). Biceps tendons (mean and 95% confidence interval [CI]) (4.7 mm [4.4, 5.0] versus 3.2 mm [2.9, 3.5]) and supraspinatus tendons (6.4 mm [5.9, 6.8] versus 4.9 mm [4.4, 5.3]) were thicker and peak humerothoracic elevation (139° [135°, 146°] versus 150° [146°, 155°]) and glenohumeral external rotation (35° [26°, 46°] versus 51° [41°, 58°]) were reduced in the DM group compared with the control group (P<.05). In the DM group, SIF was correlated to biceps tendon thickness, DASH score, and shoulder motion (r=.44-.51, P<.05). The SIF score and shoulder strength explained 64% of the DASH scores (P<.01). LIMITATIONS: Because this was a cross-sectional study design, a cause-effect relationship could not be established. CONCLUSIONS: Accumulation of AGEs in the connective tissues of individuals with DM appears to be associated with increased tendon thickness and decreased shoulder joint mobility and upper extremity function. Physical therapists should be aware of these possible metabolic effects on structure, movement, and disability when treating people with diabetes.
BACKGROUND: Accumulation of advanced glycation end products (AGEs) is thought to contribute to limited joint mobility in people with diabetes mellitus (DM), but the relationships among AGEs, shoulder structural changes, movement, and disability are not understood. OBJECTIVE: The purpose of this study was to determine the differences and relationships among skin intrinsic fluorescence (SIF), a proxy measure of AGEs, biceps and supraspinatus tendon thickness, upper extremity movement, and disability in groups with and without DM. DESIGN: This was a cross-sectional, case-control study. METHODS: Fifty-two individuals participated: 26 with type 2 DM and 26 controls matched for sex, age, and body mass index. The main outcome measures were: SIF; biceps and supraspinatus tendon thickness; 3-dimensional peak shoulder motion; and Disability of the Arm, Shoulder and Hand (DASH) questionnaire scores. RESULTS: Mean SIF measurements were 19% higher in the DM group compared with the control group (P<.05). Biceps tendons (mean and 95% confidence interval [CI]) (4.7 mm [4.4, 5.0] versus 3.2 mm [2.9, 3.5]) and supraspinatus tendons (6.4 mm [5.9, 6.8] versus 4.9 mm [4.4, 5.3]) were thicker and peak humerothoracic elevation (139° [135°, 146°] versus 150° [146°, 155°]) and glenohumeral external rotation (35° [26°, 46°] versus 51° [41°, 58°]) were reduced in the DM group compared with the control group (P<.05). In the DM group, SIF was correlated to biceps tendon thickness, DASH score, and shoulder motion (r=.44-.51, P<.05). The SIF score and shoulder strength explained 64% of the DASH scores (P<.01). LIMITATIONS: Because this was a cross-sectional study design, a cause-effect relationship could not be established. CONCLUSIONS: Accumulation of AGEs in the connective tissues of individuals with DM appears to be associated with increased tendon thickness and decreased shoulder joint mobility and upper extremity function. Physical therapists should be aware of these possible metabolic effects on structure, movement, and disability when treating people with diabetes.
Authors: Patricia A Cleary; Barbara H Braffett; Trevor Orchard; Timothy J Lyons; John Maynard; Catherine Cowie; Rose A Gubitosi-Klug; Jeff Way; Karen Anderson; Annette Barnie; Stephan Villavicencio Journal: Diabetes Technol Ther Date: 2013-06 Impact factor: 6.118
Authors: N Verzijl; J DeGroot; S R Thorpe; R A Bank; J N Shaw; T J Lyons; J W Bijlsma; F P Lafeber; J W Baynes; J M TeKoppele Journal: J Biol Chem Date: 2000-12-15 Impact factor: 5.157
Authors: Mary E Larkin; Annette Barnie; Barbara H Braffett; Patricia A Cleary; Lisa Diminick; Judy Harth; Patricia Gatcomb; Ellen Golden; Janie Lipps; Gayle Lorenzi; Carol Mahony; David M Nathan Journal: Diabetes Care Date: 2014-04-10 Impact factor: 19.112
Authors: Christopher J Sorensen; Mary K Hastings; Catherine E Lang; Janet B McGill; B Ruth Clark; Kathryn L Bohnert; Michael J Mueller Journal: J Diabetes Complications Date: 2017-03-18 Impact factor: 2.852
Authors: Barbara E K Klein; Kayla L Horak; John D Maynard; Kristine E Lee; Ronald Klein Journal: Ophthalmic Epidemiol Date: 2017-03-13 Impact factor: 1.648
Authors: Hans Drenth; Sytse Zuidema; Steven Bunt; Ivan Bautmans; Cees van der Schans; Hans Hobbelen Journal: Eur Rev Aging Phys Act Date: 2016-03-04 Impact factor: 3.878
Authors: Mary K Hastings; Hyo-Jung Jeong; Christopher J Sorensen; Jennifer A Zellers; Ling Chen; Kathryn L Bohnert; Darrah Snozek; Michael J Mueller Journal: Foot (Edinb) Date: 2020-03-30